Unknown

Dataset Information

0

Reply to Decroo et al.: High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis.

ABSTRACT:

SUBMITTER: Dooley KE 

PROVIDER: S-EPMC7301745 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Reply to Decroo <i>et al.</i>: High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis.

Dooley Kelly E KE   Miyahara Sachiko S   von Groote-Bidlingmaier Florian F   Sun Xin X   Hafner Richard R   Rosenkranz Susan L SL   Ignatius Elisa H EH   Nuermberger Eric L EL   Moran Laura L   Donahue Kathleen K   Swindells Susan S   Vanker Naadira N   Diacon Andreas H AH  

American journal of respiratory and critical care medicine 20200601 12

Similar Datasets

Unknown High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis.
| S-EPMC7301730 | biostudies-literature
Unknown Reply to Kim et al., "Optimal Dose or Optimal Exposure? Consideration for Linezolid in Tuberculosis Treatment".
| S-EPMC7318045 | biostudies-literature
Unknown Hemani et al. reply.
| S-EPMC4404158 | biostudies-literature
Unknown Reply to Soman et al, Alffenaar et al, Metcalfe et al, and Raoult.
| S-EPMC4696596 | biostudies-literature
Unknown Reply to Topeli et al. and to Akinosoglou et al.
| S-EPMC7328319 | biostudies-literature
Unknown Reply to Gueret et al. and to Hammond et al.
| S-EPMC7193864 | biostudies-literature
Unknown Reply to Turnbull et al. and to Hulme et al.
| S-EPMC7068835 | biostudies-literature
Unknown Reply to Webb et al.
| S-EPMC1592558 | biostudies-literature
Unknown Reply to Pachai et al.
| S-EPMC8865381 | biostudies-literature
Unknown Reply to Loughlin et al.
| S-EPMC1785335 | biostudies-literature